國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Lung cancer and personalized medicin...

Ahmad, Aamir.

Lung cancer and personalized medicinecurrent knowledge and therapies /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Lung cancer and personalized medicineedited by Aamir Ahmad, Shirish Gadgeel.
其他題名:	current knowledge and therapies /
其他作者:	Ahmad, Aamir.
出版者:	Cham :Springer International Publishing :2016.
面頁冊數:	xiii, 228 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	LungsCancer
電子資源:	http://dx.doi.org/10.1007/978-3-319-24223-1
ISBN:	9783319242231$q(electronic bk.)

Lung cancer and personalized medicinecurrent knowledge and therapies /
Lung cancer and personalized medicinecurrent knowledge and therapies /[electronic resource] :edited by Aamir Ahmad, Shirish Gadgeel. - Cham :Springer International Publishing :2016. - xiii, 228 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.8930065-2598 ;. - Advances in experimental medicine and biology ;946..

1 Lung Cancer Statistics -- 2 Epidemiology of Lung Cancer -- 3 Lung Cancer In Never Smokers -- 4 Immune Therapy -- 5 Anti-angiogenesis in personalized therapy of lung cancer -- 6 Target therapy in Lung Cancer -- 7 Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: an update -- 8 KRAS-Mutant Lung Cancers in the Era of Targeted Therapy -- 9 Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer -- 10 Chemotherapy Resistance in Lung Cancer -- 11 Current state of metal-based drugs for the efficient therapy of lung cancers and lung metastases.

This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer--statistics and epidemiology of lung cancer--along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer--immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies.

ISBN: 9783319242231$q(electronic bk.)

Standard No.: 10.1007/978-3-319-24223-1doiSubjects--Topical Terms:

531376
Lungs
--Cancer

LC Class. No.: RC280.L8

Dewey Class. No.: 616.9942406

Lung cancer and personalized medicinecurrent knowledge and therapies /
LDR:02535nmm a2200325 a 4500 001 482134
003 DE-He213
005 20160802153656.0
006 m d
007 cr nn 008maaau
008 161007s2016 gw s 0 eng d
020 $a 9783319242231$q(electronic bk.)
020 $a 9783319242217$q(paper)
024 7 $a 10.1007/978-3-319-24223-1 $2 doi
035 $a 978-3-319-24223-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.9942406 $2 23
090 $a RC280.L8 $b L963 2016
245 0 0 $a Lung cancer and personalized medicine $h [electronic resource] : $b current knowledge and therapies / $c edited by Aamir Ahmad, Shirish Gadgeel.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xiii, 228 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.893
505 0 $a 1 Lung Cancer Statistics -- 2 Epidemiology of Lung Cancer -- 3 Lung Cancer In Never Smokers -- 4 Immune Therapy -- 5 Anti-angiogenesis in personalized therapy of lung cancer -- 6 Target therapy in Lung Cancer -- 7 Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: an update -- 8 KRAS-Mutant Lung Cancers in the Era of Targeted Therapy -- 9 Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer -- 10 Chemotherapy Resistance in Lung Cancer -- 11 Current state of metal-based drugs for the efficient therapy of lung cancers and lung metastases.
520 $a This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer--statistics and epidemiology of lung cancer--along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer--immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies.
650 0 $a Lungs $x Cancer $x Treatment. $3 531376
650 0 $a Personalized medicine. $3 713807
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Molecular Medicine. $3 273932
650 2 4 $a Internal Medicine. $3 273839
650 2 4 $a Oncology. $3 195181
700 1 $a Ahmad, Aamir. $3 737205
700 1 $a Gadgeel, Shirish. $3 738662
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-24223-1
950 $a Biomedical and Life Sciences (Springer-11642)